Page 8 - கீந் சிகிச்சைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

During the last session, Sio Gene Therapies Inc. (NASDAQ:SIOX)’s traded shares were 0.33 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $2.49, reflecting an intraday gain of 1.63% or $0.04. The 52-week high for the SIOX share is $5.74, that puts it down -130.52 from that peak though still a striking 25.3% gain since the share price plummeted to a 52-week low of $1.86. The company’s market capitalization is $144.27M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 625.18K shares over the past three months.

Vanguard total stock market index fundDelaware group equity fds healthcare fundSio gene therapies incSio gene therapiesGene therapiesWall streetAre poisedTake offConsonance capital managementRubric capital managementMutual fundsDelaware group equity fdsDelaware healthcareNasdaq sioxSio gene therapies incIox stock